Low-carbohydrate breakfast intervention for managing type 2 diabetes
Long-term Impact of a Low-carbohydrate Versus Low-fat Breakfast on Blood Glucose Control in Type 2 Diabetes
This study tests if eating a low-carb breakfast can help people with type 2 diabetes manage their blood sugar better compared to a regular low-fat breakfast.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 280 (estimated) |
| Ages | 30 Years to 79 Years |
| Sex | All |
| Sponsor | University of British Columbia Academic / other |
| Locations | 1 site (Kelowna, British Columbia) |
| Trial ID | NCT06814171 on ClinicalTrials.gov |
What this trial studies
This clinical trial investigates the effects of a low-carbohydrate breakfast on blood glucose levels in individuals with type 2 diabetes. Participants will receive guidance to consume a low-carb high-fat breakfast for one year, compared to a standard low-fat breakfast control group. The study aims to assess improvements in glycemic control, variability, body weight, and feelings of hunger. The primary outcome will be measured through HbA1c levels, while secondary outcomes will include glucose monitoring metrics and body composition changes.
Who should consider this trial
Good fit: Ideal candidates are adults aged 30-79 with physician-diagnosed type 2 diabetes who are on stable medication.
Not a fit: Patients using exogenous insulin, taking multiple glucose-lowering medications, or those with certain medical conditions may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly improve glycemic control and overall health for patients with type 2 diabetes.
How similar studies have performed: Previous studies have shown positive outcomes with low-carbohydrate dietary interventions for diabetes management, suggesting this approach may be effective.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: i) physician-diagnosed T2D, ii) 30-79 years old and iii) on stable medication for at least 3 months Exclusion Criteria: i) Use of exogenous insulin; ii) taking more than 3 glucose lowering medications; iii) ongoing medical treatment for diseases such as cancer, auto-immune or inflammatory disease, or kidney disorders; iv) allergy, intolerance or aversion to eggs or any other dietary restrictions (e.g., vegan, breakfast skipping) that will prevent them from following the standardized study diets; v) being unable to follow the controlled diet instructions; vi) currently following a low-carbohydrate or very low-carbohydrate diet (ketogenic diet); vii) currently pregnant or lactating, or planning on becoming pregnant within the next 12 months; viii) with scheduled surgery or medical intervention that prevents following study diet; and ix) being unable to follow remote guidance by internet or smartphone.
Where this trial is running
Kelowna, British Columbia
- University of British Columbia - Okanagan — Kelowna, British Columbia, Canada (Recruiting)
Study contacts
- Study coordinator: Barbara Oliveira, PhD
- Email: barbara.oliveira@ubc.ca
- Phone: 250 8599900
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.